Community Health Systems: Tough Q3 Stifles Recovery - Potentially Sets Up Contrarian Trade

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there. As we can see above, revenues only slightly exceeded last year's figure, reaching $3.1bn, but fell sequentially, from $3.14bn, and operating income fell substantially, to ...